tiziana-logo.png
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
04 juin 2024 09h00 HE | Tiziana Life Sciences Ltd.
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
LOGO.png
Draganfly Announces Agreement to Pilot Drone Delivery Services Program for Mass General Brigham’s Home Hospital
16 janv. 2024 07h15 HE | Draganfly Inc
Just-in-time medical drone deliveries by Draganfly to include critical medicines, technical equipment, and laboratory work to benefit patient care. Boston, MA., Jan. 16, 2024 (GLOBE NEWSWIRE)...
Coming Soon to a Cli
Coming Soon to a Clinic Near You: Top 12 Emerging Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
14 juin 2023 11h15 HE | Mass General Brigham
Boston, MA, June 14, 2023 (GLOBE NEWSWIRE) -- Mass General Brigham today revealed the annual “Disruptive Dozen,” 12 emerging technologies with the greatest potential to impact health care in the...
Logo.png
IMUNON CEO to Discuss Company’s Novel Non-viral DNA Therapy Option at the Mass General Brigham World Medical Innovation Forum 2023
12 juin 2023 08h30 HE | Imunon, Inc.
Dr. Corinne Le Goff will highlight the breakthrough potential of IMNN-001 for the treatment of ovarian cancer during a panel discussion LAWRENCEVILLE, N.J., June 12, 2023 (GLOBE NEWSWIRE) --...
Mass General Brigham launches community health vans
27 janv. 2021 10h19 HE | Mass General Brigham
Boston, MA, Jan. 27, 2021 (GLOBE NEWSWIRE) -- To better support the people who live and work in communities hardest hit by COVID-19, Mass General Brigham is launching a fleet of community health...